Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560014 · ClinicalTrials.gov registry record · NA
Nutrient Levels Alter Transplant Outcome
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00560014: Completed NA study, sponsored by University of Cincinnati.
NCT00560014 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00560014, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.
Interventions
- DIETARY_SUPPLEMENT Arginine and canola oil
- DIETARY_SUPPLEMENT Coromega and Arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 1997-09 |
| Est. Completion | 2005-05 |
| Phase | NA |
What the finished NCT00560014 record still lists
NCT00560014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Arginine and canola oil is the first listed.
NCT00560014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00560014 about?
NCT00560014 is a clinical study titled "Nutrient Levels Alter Transplant Outcome". The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with argin...
What is the current status of trial NCT00560014?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 1997-09. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00560014?
The interventions under investigation include: Arginine and canola oil (DIETARY_SUPPLEMENT), Coromega and Arginine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00560014?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00560014's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia